- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Merrill, B. J.
- Articles by Holm, C.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Merrill, B. J.
- Articles by Holm, C.
The RAD52 Recombinational Repair Pathway is Essential in pol30 (PCNA) Mutants That Accumulate Small Single-Stranded DNA Fragments During DNA Synthesis
Bradley J. Merrilla and Connie Holmaa Department of Pharmacology, Division of Cellular and Molecular Medicine, Center for Molecular Genetics, University of California, San Diego, La Jolla, Calfornia 92093-0651
Corresponding author: Connie Holm, Department of Pharmacology, Center for Molecular Genetics, Division of Cellular and Molecular Medicine, University of California, San Diego, 9500 Gilman Drive, Mail Code 0651, La Jolla, CA 92093-0651, cholm{at}ucsd.edu (E-mail).
Communicating editor: F. WINSTON
| ABSTRACT |
|---|
To identify in vivo pathways that compensate for impaired proliferating cell nuclear antigen (PCNA or Pol30p in yeast) activity, we performed a synthetic lethal screen with the yeast pol30-104 mutation. We identified nine mutations that display synthetic lethality with pol30-104; three mutations affected the structural gene for the large subunit of replication factor C (rfc1), which loads PCNA onto DNA, and six mutations affected three members of the RAD52 epistasis group for DNA recombinational repair (rad50, rad52, and rad57 ). We also found that pol30-104 displayed synthetic lethality with mutations in other members of the RAD52 epistasis group (rad51 and rad54), but not with mutations in members of the RAD3 nor the RAD6 epistasis group. Analysis of nine different pol30 mutations shows that the requirement for the RAD52 pathway is correlated with a DNA replication defect but not with the relative DNA repair defect caused by pol30 mutations. In addition, mutants that require RAD52 for viability (pol30-100, pol30-104, rfc1-1 and rth1
) accumulate small single-stranded DNA fragments during DNA replication in vivo. Taken together, these data suggest that the RAD52 pathway is required when there are defects in the maturation of Okazaki fragments.
THE proliferating cell nuclear antigen, PCNA or Pol30p in yeast, has been implicated in many of the pathways that allow rapid and precise replication of the genome. The crystal structure of PCNA reveals that it is a homotrimeric doughnut-shaped structure with a central pore suitable for surrounding double-stranded DNA molecules (![]()
![]()
![]()
![]()
![]()
or
and enhances its ability to replicate DNA processively (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
In addition to its role in DNA replication, PCNA is also important for several aspects of DNA repair. In vivo, mutations in POL30 cause sensitivities to genotoxic agents such as UV and MMS (methyl methane sulfonate) (![]()
![]()
![]()
![]()
![]()
![]()
Interestingly, PCNA also plays an important role in preventing the production of mutations. Two pol30 mutations, pol30-104 and pol30-52, cause mutator phenotypes that appear to be epistatic to mutations in members of the mismatch repair (MMR) pathway (![]()
![]()
![]()
mutation suggests that Rth1p may be important for a mutation avoidance pathway distinct from MMR (![]()
![]()
To further elucidate the role PCNA plays in these processes, we used a synthetic lethal screen to identify gene products required for viability when the functions of PCNA are impaired by the pol30-104 mutation. The isolation of rad50, rad52 and rad57 in this screen reveals that recombinational repair provides a compensatory mechanism by which pol30-104 mutants retain viability. The synthetic lethality observed in pol30 rad50 double mutants correlates with a disruption in the cell division cycle caused by the pol30 mutation. Moreover, mutations displaying synthetic lethality with rad52 cause an accumulation of small single-stranded DNA (ssDNA) fragments during DNA synthesis in vivo. Taken together, these observations suggest that the RAD52 pathway is important for viability when there are defects in Okazaki fragment maturation.
| MATERIALS AND METHODS |
|---|
Strains and plasmids:
All strains used in this study have an S288C background and are listed in Table 1. Standard genetic techniques and media were used in the construction and growth of each strain (![]()
ade2 ade3 leu2 ura3-52 his3) to make strains CH2208 (MATa ade2 ade3 leu2 ura3-52 lys2-801 pol30-104.LEU2) and CH2210 (MAT
ade2 ade3 leu2 ura3-52 his3 pol30-104.LEU2) was performed as described (![]()
(CH2307) and rad54
(CH2312) strains were kindly provided by DAVID SCHILD. Plasmids used to construct rad1
(CH2373), rad6
(CH2374) and rad14
(CH2375) strains were kindly provided by SATYA PRAKASH.
|
Cells were grown in YEPD (rich) or SD (minimal) medium. YEPD is 1% yeast extract, 2% bacto-peptone and 2% dextrose; SD is 0.67% yeast nitrogen base and 2% dextrose. For synthetic complete (SC) media, 20 mg of uracil, adenine, tryptophan and histidine, 30 mg of lysine, and 60 mg of leucine were added to 1 liter of SD media. 5-Fluoro-orotic acid (5-FOA) plates were made as described previously (![]()
Plasmids were constructed using standard techniques of molecular biology (![]()
|
Synthetic lethal screen:
The synthetic lethal screen used in this work is based on the plasmid dependence assay developed by ![]()
ade2 ade3 ura3 leu2 his3 pol30-104.LEU2) was transformed with the screening plasmid pCH1589 (POL30 ADE3 URA3 CEN/ARS). Transformants were grown at 35° in selective medium to mid-log phase and plated onto YEPD plates. The plates were placed in a UV Stratalinker 1800 (Stratagene, La Jolla, CA) and mutagenized to ~80% viability (80100 J/m2). Approximately 200,000 mutagenized colonies were assayed for sectoring after growing for 7 days at 35°. Non-sectored red colonies were struck for single colonies onto fresh YEPD and 5-FOA plates to confirm the dependence on pCH1589 for viability.
Secondary and tertiary tests were performed to identify non-sectoring mutants that had single-gene mutations causing a dependency on POL30 for viability. To determine if non-sectoring mutants were dependent on the POL30 gene on pCH1589 for viability, mutants were transformed with pCH1093 (HIS3) or pCH1586 (POL30 HIS3). Mutants that regained the ability to sector on YEPD and grow on 5-FOA when transformed with pCH1586 (POL30 HIS3) but not when transformed with pCH1093 (HIS3) were determined to be dependent on POL30 for viability. Mutants were subsequently analyzed to determine if a mutation causing POL30 dependence was located at a single locus by backcrossing with unmutagenized strain CH2208 (MATa ade2 ade3 ura3 leu2 lys2 pol30-104.LEU2) or strain CH2210 (MAT
ade2 ade3 ura3 leu2 his3 pol30-104.LEU2).
Phenotypic characterization of POL30-dependant mutants:
To determine if any of the mutations causing inviability in a pol30-104 background also caused defects in a POL30/pol30 background, non-sectoring strains carrying plasmid pCH1589 (POL30 ADE3 URA3 CEN/ARS) were assayed for sensitivities to temperature and DNA damage. POL30 dependent mutants were spotted onto YEPD plates placed at 37°, 30°, 25°, 20° and 14° and on YEPD plates containing 0.02% MMS or 0.04 M HU at 30°.
Cloning of slp (s ynthetic lethal with pol30) mutations by suppression:
Since the slp2 and slp3 mutations caused sensitivities to HU and MMS, we identified these genes by isolating genomic library plasmids that suppressed the HU and MMS sensitivities. An URA3 CEN/ARS genomic library (pCH1020) (![]()
![]()
Specificity of observed synthetic lethality:
To determine if pol30-104 displayed synthetic lethality with different rad mutations, strain CH2161 (pol30-104.LEU2) was crossed with strain CH1637 (rad52
::URA3), and strain CH2321 (pol30-104.TRP1) was crossed with strains CH2307 (rad51
::LEU2) and CH2312 (rad54
LEU2). Strain CH2319 (pol30-104.TRP1) was crossed with strains CH2373 (rad1
::LEU2), CH2374 (rad6
::hisG-URA3-hisG) and CH2375 (rad14
::URA3). To determine if rad52 displayed synthetic lethality with DNA replication/repair genes other than pol30-104, strain CH1637 (rad52
) was crossed with strains CH2359 (rfc1-5) CH2145 (pol1-16), CH2152 (cdc17-1), CH526 (cdc2-1), CH2234 (pol2-11) and CH2235 (pol2-12). Diploids were selected, sporulated, and germinated at 25° for pol1, pol2, cdc2 and cdc17 mutants, or 35° for pol30-104 and rfc1-5 mutants. The number of expected double mutants was determined by examining the phenotypes of all tetrads in which two or more spores survived.
pol30 allele-specific synthetic lethality:
Strain CH2335 {(pol30:: LEU2 rad50
::hisG leu2 trp1
63 ura3-52 [pCH1511 (URA3 POL30)]} was transformed with TRP1 plasmids containing different pol30 alleles (Table 2). Transformants were grown in synthetic medium to select for both the POL30 URA3 and the pol30-x TRP1 plasmids. Stationary cultures and serial dilutions were spotted onto SD plates (to determine relative concentration of cells spotted) and 5FOA plates [to evaluate growth without the pCH1511 (POL30 URA3) covering plasmid].
Repair capacity of pol30 mutants:
To compare the relative sensitivities of the pol30 mutants to DNA damage, mutants were assayed for growth on either YEPD plates containing different amounts of MMS or YEPD plates exposed to UV in a Stratalinker 1800. Stationary cultures of pol30::LEU2 strains containing the indicated pol30 alleles on CEN/ARS plasmids were serially diluted and spotted onto YEPD plates. To determine the sensitivities of pol30 mutants to UV, these plates were irradiated with 0, 30, 55, 80, 100 or 150 J/m2 of UV light. To determine the sensitivities of pol30 mutants to MMS, pol30 mutants were also spotted onto YEPD plates containing 0.005%, 0.01%, 0.02% or 0.03% MMS. Plates were incubated at 25° or 35° for 2 days.
Flow cytometry:
Cultures of pol30::LEU2 strains containing the indicated pol30 alleles on CEN/ARS plasmids (Table 2) were grown to log phase at 35°. An aliquot of the culture was taken and fixed in 70% ethanol. The remaining 35° culture was split and incubated at 25° or 14°. Aliquots were taken from the 25° culture after 4.5 hr and from the 14° culture after 18 hr, and then fixed in 70% ethanol. Fixed cells were sonicated, treated with 1 mg/ml Rnase A, and stained with 50 µg/ml propidium iodide prior to microfluorometric analysis (FACS) on a Becton Dickinson fluorescence activated cell sorter.
Alkaline sucrose velocity sedimentation gradients:
To determine if mutations affect the processing of Okazaki fragments, DNA from pulse-labeled cultures was resolved by alkaline sucrose velocity sedimentation. To focus our analysis solely on chromosomal DNA replication, all these experiments were performed with rho° strains lacking mitochondrial DNA (![]()
![]()
![]()
![]()
DNA was isolated from the fixed cells as previously described (![]()
![]()
The size of ssDNA in each gradient fraction was determined by using the equation (![]()
coefficient for our gradients, DNA standards (49 kb and 5.5 kb) were sedimented through parallel alkaline sucrose gradients. The 49 kb DNA sedimented in fraction #11, and the 5.5 kb DNA sedimented in fraction #5. The
coefficient was determined to be 0.36 in our gradients and was used to determine the size of ssDNA in each gradient fraction. A value of 0.36 was obtained by others using similar gradients (| RESULTS |
|---|
Identification of mutations causing synthetic lethality with pol30-104:
To identify mutations causing synthetic lethality with pol30-104, we used a red/white colony sectoring assay (see MATERIALS AND METHODS). Of the 200,000 colonies screened, ten exhibited a Slp- (synthetic lethality with pol30-104) phenotype. Backcrosses of the slp mutants with the unmutagenized parent strain revealed that each mutant carried a single recessive mutation causing the Slp- phenotype. The ten slp mutations fell into five complementation groups. In addition to the dependency on POL30, mutations in groups 2, 3 and 4 caused sensitivities to MMS and HU.
The identities of complementation groups 1, 2, 3, and 4 were elucidated using a variety of methods. For group 1, the slp mutation was very closely linked to HIS3 (14PD:0NPD:1T), as is the gene for the large subunit of replication factor C (RFC1). Since RFC is responsible for loading PCNA onto DNA (![]()
![]()
![]()
) to complement the HU and MMS sensitivities of strain CH2294 (slp4). Thus, two classes of mutations, those in RFC1 and those in members of the RAD52 epistasis group, were identified as displaying synthetic lethality with pol30-104. While it is not surprising that rfc1 mutants were isolated in this screen, it is striking that mutations in three different members of the RAD52 epistasis group exhibit synthetic lethality with pol30-104.
Specificity of synthetic lethality:
To determine if pol30-104 displays synthetic lethality only with specific types of mutations affecting genes in the RAD52 epistasis group, we determined whether pol30-104 exhibits synthetic lethality with null alleles of members of the RAD52 epistasis group. Tetrad analysis was performed on diploids heterozygous for the pol30-104 allele and a rad51
, rad52
, or rad54
mutation. The pol30-104 mutation displayed synthetic lethality with rad52
(0 of 13 expected double mutants were viable) and rad54
(0 of 10 expected double mutants were viable). Six of the nine expected pol30-104 rad51
double mutants grew poorly at 35° and were inviable at 25°; the remaining three pol30-104 rad51 double mutants failed to grow even at 35°. Taken together, these crosses indicate that general disruptions in the RAD52 pathway are fatal to pol30-104 mutants.
To determine whether the synthetic lethality between pol30-104 and mutations in repair genes was specific to the RAD52 repair pathway, the viabilities of pol30-104 strains carrying mutations in other DNA repair genes were examined. Tetrad analysis was performed on diploids heterozygous for the pol30-104 allele and a deletion allele of rad1, rad14 (RAD3 epistasis group), or rad6 (RAD6 epistasis group). The pol30-104 mutation did not display synthetic lethality with rad1
(18 of 19 expected double mutants were viable), rad14
(7 of 7 expected double mutants were viable) nor rad6
(22 of 23 expected double mutants were viable). This observation rules out the possibility that pol30-104 strains require all DNA repair processes to be intact for viability, and it points to a specific requirement for the RAD52 pathway in pol30-104 strains.
To determine if the RAD52 pathway is required when cells carry general defects in DNA synthesis rather than defects specific to pol30-104 mutants, the viability of DNA synthesis mutants with a rad52
background was examined. Tetrad analysis was performed on diploids heterozygous for the rad52
::URA3 mutation and a mutation in one of various DNA synthesis genes. The rad52
mutation did not display synthetic lethality with cdc17-1 (DNA polymerase
; 5 of 5 expected double mutants were viable), pol1-16 (DNA polymerase
; 8 of 8 expected double mutants were viable), pol2-11 (DNA polymerase
; 10 of 12 expected double mutants were viable), pol2-12 (DNA polymerase
; 16 of 18 expected double mutants were viable) nor cdc2-1 (DNA polymerase
; 15 of 22 expected double mutants were viable). These results are consistent with data demonstrating rad52 does not exhibit synthetic lethality with these mutations affecting the three essential yeast DNA polymerases (![]()
does display synthetic lethality with rfc1-5 (0 of 46 expected double mutants were viable). This result is not surprising, because RFC is responsible for loading PCNA onto DNA (![]()
![]()
![]()
![]()
![]()
pol30 mutations exhibit allele-specific synthetic lethality with rad50
:
While the previous experiments demonstrate that cells require an intact RAD52 pathway when there are defects in PCNA and RFC, other experiments are necessary to determine the specific defect in pol30-104 mutants that causes a requirement for an intact RAD52 pathway. For example, it is possible that any defect in Pol30p may cause a requirement for the RAD52 pathway. If so, one would expect that all pol30 mutations would exhibit synthetic lethality with rad50
. Alternatively, the requirement for an intact RAD52 pathway may occur when a mutation in POL30 affects one particular in vivo function. If so, one would expect that pol30 mutations would exhibit an allele-specific synthetic lethality with rad50. Thus, determining the requirement for the RAD52 pathway in different pol30 mutants may prove useful in determining the defect in pol30-104 mutants that causes the requirement for the RAD52 pathway.
To determine whether the requirement for the RAD52 pathway is specific to certain pol30 alleles, we examined the viability of strains carrying various pol30 alleles in combination with rad50. To simplify the analysis, each strain initially carried a POL30 URA3 plasmid to ensure viability. The strains had the following genotype: pol30::LEU2 rad50
::hisG ura3 trp1[pCH1511 (POL30 URA3)] [pCH1594 to pCH1608 (pol30-x TRP1)] (see Table 2). Serial dilutions of each strain were transferred onto 5-FOA plates to select for loss of the POL30 URA3 plasmid pCH1511. These plates revealed that synthetic lethality with rad50 occurs only with specific pol30 alleles (Figure 1). In group I, pol30-102, -105, -113 and -114 exhibited good viability in a rad50 background at 35° (25° and 14° data not shown); the pol30-105 mutation was unusual, in that it caused synthetic lethality at 14° (data not shown). In group II, pol30-100, -103, -104, -106, -108 and -112 displayed synthetic lethality with rad50 at 35°, 25° and 14°. It is most economical to conclude that these two groups of pol30 alleles differ in their detrimental effects on the cells. While defects caused by group I mutations appear to cause little need for Rad50p, defects caused by group II mutations cause a requirement for Rad50p. By identifying defects caused by each allele, we hoped to begin to understand what defect in Pol30p causes the requirement for an intact RAD52 pathway. Therefore, we next characterized pol30 mutant strains for a number of different phenotypes.
|
Location of mutations in Pol30p:
To determine if a definable region of Pol30p is essential for viability in a rad50 background, the location of each pol30 mutation was mapped onto the three-dimensional structure of Pol30p (![]()
|
DNA repair capacity of pol30 mutants:
To determine whether synthetic lethality is the result of an additive defect in DNA repair caused by pol30 and rad50 mutations, the relative sensitivities to MMS and UV were determined for each pol30 mutant. None of the ten pol30 mutations in this study caused more than a slight sensitivity to UV (data not shown), and the mutations that exhibited a slight sensitivity to UV were distributed in group I and group II. In contrast, all pol30 mutations caused at least a moderate MMS-sensitive phenotype (Figure 3). Three of the group I mutations (pol30-102, -113, and -114) caused an intermediate sensitivity to MMS, and the pol30-105 mutation caused little sensitivity to 0.005% and 0.01% MMS. The group II alleles caused a wide range of sensitivities to MMS. Some group II mutations (pol30-100, -104, and -112) caused greater MMS sensitivity than that caused by group I mutations. Importantly, others (pol30-103, -106, and -108) caused a lesser sensitivity than the sensitivity caused by group I alleles. Since the degree of sensitivity to UV or MMS does not correlate with the observation of synthetic lethality with rad50, it is unlikely that it is simply an overall repair defect caused by pol30 mutations that causes a requirement for an intact RAD52 pathway.
|
Synthetic lethality with rad50 correlates with cell cycle alterations in pol30 mutants:
Microfluorometric analysis (FACS) was used to determine whether the pol30 mutations affect the overall ability to efficiently replicate the genome and proceed through the cell division cycle. Cultures growing exponentially at 35° were shifted to 25° or 14° for three generation times and then prepared for FACS analysis. The group I mutants exhibited FACS profiles that were indistinguishable from the POL30 strain at 35° (Figure 4). In contrast, all six group II pol30 mutations caused an accumulation of G2 cells, which varied in severity with temperature: two mutations (pol30-100 and pol30-112) caused an accumulation of G2 cells at all temperatures; four mutations (pol30-103, -104, -106, and -108) caused mild perturbations at 35° but profound alterations at 14°. In addition, the group I pol30-105 mutation yielded a normal FACS profile at 35° (the temperature at which it retains viability in a rad50 background), and it caused an enrichment of S and G2 cells at 14° (the temperature at which it exhibits synthetic lethality with rad50). These results reveal a correlation between the requirement for the RAD52 pathway in pol30 mutants and DNA replication defects caused by pol30 mutations.
|
Synthetic lethality with rad50 correlates with an accumulation of small single stranded DNA fragments during DNA synthesis in vivo:
Since Pol30p is important for many DNA replication processes, the requirement for the RAD52 pathway in pol30 mutants could be caused by any of a number of DNA replication defects. However, it is striking that mutations affecting proteins required for Okazaki fragment maturation in vitro (DNA ligase, PCNA, RFC, and FEN-1) all display synthetic lethality with mutations affecting the RAD52 pathway (![]()
![]()
![]()
![]()
![]()
To determine if mutations affecting these DNA replication proteins affect the maturation of Okazaki fragments in vivo, alkaline sucrose velocity sedimentation was used to determine if mutants accumulate small ssDNA fragments during DNA synthesis in vivo. Exponentially growing cultures were labeled with 14C-uracil for at least six generation times to label the bulk of genomic DNA. A short pulse of 3H-uracil was then added to the cultures to differentially label newly synthesized DNA. The DNA was then isolated from these labeled cells and resolved by size by sedimentation through an alkaline sucrose density gradient. At 14°, group I mutants (pol30-102 and pol30-114) did not accumulate small ssDNA fragments and had sedimentation profiles similar to the POL30 strain (Figure 5 and Table 3). In contrast, group II pol30 mutants (pol30-100 and pol30-104) had a three- to fourfold increase in the accumulation of small ssDNA fragments during DNA synthesis at restrictive temperature. Furthermore, both rth1
and rfc1-1 mutations, which display synthetic lethality with rad52, also caused an accumulation of small ssDNA fragments at restrictive temperature. A concomitant decrease in the synthesis of large DNA molecules was observed at 14° in group II pol30 mutants and the rfc1-1 mutant. For the samples exhibiting an accumulation of small ssDNA, the DNA fragments in the 3H peak fractions corresponded in size to unligated Okazaki fragments (approximately 500 bp) (![]()
![]()
|
|
If the requirement for the RAD52 pathway in Group II pol30 mutants is caused by defects in Okazaki fragment processing, group II pol30 mutations should cause an accumulation of small ssDNA molecules during DNA synthesis even at their "permissive" temperature (a temperature at which they display synthetic lethality with rad50). To test this hypothesis, DNA was isolated from pol30 mutants that were pulse-labeled at 35°, and it was analyzed on alkaline sucrose velocity sedimentation gradients (Figure 6). The profiles for Group I pol30 mutants (pol30-102 and pol30-114) were similar to the profiles for POL30 strain. In contrast, group II mutations (pol30-100 and pol30-104) caused an accumulation of small ssDNA fragments in newly synthesized DNA (19% and 22%, respectively) (Table 3). In addition, the amount of 3H label in the bottom nine fractions (56% for pol30-100 and 57% for pol30-104) indicate that these mutants are capable of synthesizing large DNA molecules at 35°. While the defects observed at 35° were substantially less than those observed at 14°, the accumulation of small ssDNA fragments suggests that these mutations cause defects in lagging-strand DNA synthesis even at "permissive" temperatures. Thus, these results are consistent with the hypothesis that the requirement for an intact RAD52 pathway is caused by defects in Okazaki fragment maturation.
|
| DISCUSSION |
|---|
Using a colony-sectoring assay, we identified mutations affecting members of the RAD52 epistasis group that display synthetic lethality with pol30-104. This synthetic lethality is specific, because pol30-104 mutants do not require the function of proteins belonging to the RAD3 or RAD6 epistasis groups. The RAD52 pathway does not appear to be required when there are defects in general DNA replication and repair processes caused by mutations in any of the three essential DNA polymerases (Pol
, Pol
and Pol
). The allele specificity of synthetic lethality demonstrates that it is linked to a disruption in the cell division cycle caused by pol30 mutations. Furthermore, pol30 alleles that exhibit synthetic lethality with rad50 also exhibit an accumulation of short single strands in newly synthesized DNA.
The outcome of the screen for synthetic lethality suggests that we achieved good recovery of candidate mutations. Three of the nine identified mutations affect the structural gene for replication factor C. The RFC complex and Pol30p physically interact (![]()
![]()
![]()
![]()
The DNA sedimentation profiles in this study are consistent with previously published sedimentation profiles. Previously, only chronically labeled DNA was examined in sedimentation velocity gradients; only small differences were observed between mutant and wild-type (<25% change in the number-average molecular weight of DNA), even when pol30 and rfc1 mutants were grown at their restrictive temperature (![]()
![]()
Taken together with other published data, the results of this synthetic lethal screen provide additional insight into the role of Pol30p in mutation avoidance. Epistasis analysis of the spontaneous mutation rates caused by pol30 mutations, rth1 mutations, and mutations in members of the mismatch repair (MMR) pathway suggested that Pol30p and Rth1p may play a role in the MMR pathway (![]()
![]()
![]()
![]()
![]()
In addition to pol30, rfc1, and rth1, mutations affecting Cdc9p and Rad3p also display synthetic lethality with rad52 (![]()
![]()
![]()
![]()
![]()
![]()
![]()
Interestingly, the other four gene products (Pol30p, Rfc1p, Rth1p, and Cdc9p) known to be required in rad52 mutants all are important for lagging-strand DNA synthesis in vitro. Rth1p has 5' flap endonuclease and 5'-3' exonuclease activities that may be particularly important for processing Okazaki fragments (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Our observations that mutations affecting proteins required for the in vitro reconstitution of lagging-strand DNA synthesis (pol30-100, pol30-104, rfc1-1, and rth1
) all cause an accumulation of small ssDNA fragments during DNA synthesis in vivo strongly suggest that Okazaki fragment maturation is defective in these mutants in vivo. Since small ssDNA fragments accumulate only in pulse-labeled DNA and not in chronically labeled DNA, these ssDNA fragments are the result of defects in newly synthesized DNA. Furthermore, the sedimentation profile of pulse-labeled DNA from a cdc9 mutant is very similar to what we observed with pol30-100, pol30-104, rfc1-1 and rth1
mutants (![]()
Although mutations displaying synthetic lethality with rad52 may cause defects in leading-strand synthesis, it is unlikely that these defects are the cause of the synthetic lethality. Less than 50% of 3H counts were recovered from the bottom nine gradient fractions (DNA greater than 50 kb) of group II pol30 mutants at 14°. This observation suggests that these mutants also have defects in leading strand DNA synthesis at their restrictive temperature, and it is consistent with the observation that the pol30-104 mutant progresses slowly through S-phase at 14° (![]()
![]()
The precise role of the RAD52 pathway in mutants with defects in DNA replication remains unclear, but data presented here suggest some interesting possibilities. rfc1-1, rth1
, and group II pol30 mutations all cause an accumulation of single-stranded nicks or gaps, which are probably the result of defective Okazaki fragment maturation. These defects cause a requirement for the RAD52 recombinational repair pathway. One possible explanation for this requirement is that the RAD52 pathway may compensate for these defects by compensating for inefficient Okazaki fragment processing through a post-replicative repair mechanism. Replication of DNA that is normally synthesized by lagging-strand DNA synthesis could be initiated at the 3' end of a newly synthesized leading strand that has undergone a strand invasion into its sister chromatid. Elongation of this 3' end could be accomplished by using the newly synthesized leading strand of the sister chromatid as a template. This mechanism would allow regions of a genome normally replicated by lagging-strand (discontinuous) synthesis to be replicated in a continuous manner. Alternatively, the RAD52 pathway may play a less direct role in compensating for defects in Okazaki fragment maturation. The abundance of single-stranded breaks in the lagging strand of cdc9, rfc1, rth1 and pol30 mutants may present a particularly dangerous situation for rad52 mutants. Any lesion in the template for the lagging strand would result in a double-stranded break that would be lethal to a rad52 mutant.
While the interaction between DNA replication and recombination processes is not a novel concept, the mechanisms of the interaction remain elusive. For over twenty years, it has been known that recA polA double mutants in E. coli are inviable (![]()
![]()
![]()
![]()
![]()
| ACKNOWLEDGMENTS |
|---|
We thank MIKE WILSON for his assistance with the synthetic lethal screen; NEELAM AMIN and members of C. HOLM's lab for their suggestions relating to this work; DAVID SCHILD and SATYA PRAKASH for plasmids; and SATYA PRAKASH and NEELAM AMIN for their critical reading of the manuscript. This work was supported by grant GM-36510 from the National Institutes of Health (NIH). B.J.M. was partially supported by an NIH training grant CA-67754.
Manuscript received April 8, 1997; Accepted for publication October 20, 1997.
| LITERATURE CITED |
|---|
AMIN, N. S. and C. H. HOLM, 1996 In vivo analysis reveals that the interdomain region of the yeast proliferating cell nuclear antigen is important for DNA replication and DNA repair. Genetics 144:479-493[Abstract].
ASAI, T., D. B. BATES, and T. KOGOMA, 1994 DNA replication triggered by double-stranded breaks in E. coli: dependence on homologous recombination functions. Cell 78:1051-1061[Medline].
AUSUBEL, F. M., R. BRENT, R. E. KINGSTON, D. D. MOORE, J. G. SEIDMAN et al. (Editors), 1988 Current Protocols in Molecular Biology. Greene Publishing Associates and Wiley-Interscience, NY.
AYYAGARI, R., K. J. IMPELLIZZERI, B. L. YODER, S. L. GARY, and P. M. J. BURGERS, 1995 A mutational analysis of the yeast proliferating cell nuclear antigen indicates distinct roles in DNA replication and DNA repair. Mol. Cell. Biol. 15:4420-4429[Abstract].
BUDD, M. E. and J. L. CAMPBELL, 1993 DNA polymerases
and
are required for chromosomal replication in Saccharomyces cerevisiae.. Mol. Cell. Biol. 13:496-505
BUDD, M. E., K. D. WITTRUP, J. E. BAILEY, and J. L. CAMPBELL, 1989 DNA polymerase I is required for promeiotic DNA replication and sporulaton but not for X-ray repair in Saccharomyces cerevisiae.. Mol. Cell. Biol. 9:365-376
BURGERS, P. M., 1991 Saccharomyces cerevisiae replication factor C: II. Formation and activity of complexes with the proliferating cell nuclear antigen and with DNA polymerases
and
. J. Biol. Chem. 266:22698-22706
BURGERS, P. M. and B. L. YODER, 1993 ATP-independent loading of the proliferating cell nuclear antigen requires DNA ends. J. Biol. Chem. 268:19923-19926
CAO, Y. and T. KOGOMA, 1995 The mechanism of recA polA lethality: suppression by RecA-independent recombination repair activated by the lexA(Def ) mutation in Escherichia coli.. Genetics 139:1483-1494[Abstract].
FIEN, K. and B. STILLMAN, 1992 Identification of replication factor C from Saccharomyces cerevisiae : a component of the leading-strand DNA replication complex. Mol. Cell. Biol. 12:155-163
GROSS, J. D., J. GRUNSTEIN, and E. M. WITKIN, 1971 Inviability of recA- derivatives of the DNA polymerase mutant of De Lucia and Cairns. J. Mol. Biol. 58:631-634[Medline].
HARTWELL, L. H., R. K. MORTIMER, J. CULOTTI, and M. CULOTTI, 1973 Genetic control of the cell division cycle in yeast: V. Genetic analysis of cdc mutants. Genetics 74:267-286
HARTWELL, L. H. and D. SMITH, 1985 Altered fidelity of mitotic chromosome transmission in cell cycle mutants of S. cerevisiae.. Genetics 110:381-395
ISHIMI, Y., A. CLAUDE, P. BULLOCK, and J. HURWITZ, 1988 Complete enzymatic synthesis of DNA containing the SV40 origin of replication. J. Biol. Chem. 263:19723-19733
JOHNSON, R. E., G. K. KOVVALI, S. N. GUZDER, N. S. AMIN, and C. HOLM et al., 1996 Evidence for involvement of yeast proliferating cell nuclear antigen in DNA mismatch repair. J. Biol. Chem. 271:27987-27990
JOHNSON, R. E., G. K . KOVVALI, L. PRAKASH, and S. PRAKASH, 1995 Re-quirement of the yeast RTH1 5' to 3' exonuclease for the stability of simple repetitive DNA. Science 269:238-240
JOHNSTON, L. H., 1983 The cdc9 ligase joins completed replicons in baker's yeast. Mol. Gen. Genet. 190:315-317[Medline].
JOHNSTON, L. H. and K . A. NASMYTH, 1978 Saccharomyces cerevisiae cell cycle mutant cdc9 is defective in DNA ligase. Nature 274:891-893[Medline].
JOHNSTON, L. H. and D. H. WILLIAMSON, 1978 An alkaline sucrose gradient analysis of the mechanism of nuclear DNA synthesis in the yeast Saccharomyces cerevisiae.. Mol. Gen. Genet. 164:217-225[Medline].
KRANZ, J. E. and C. HOLM, 1990 Cloning by function: an alternative approach for identifying yeast homologs of genes from other organsms. Proc. Natl. Acad. Sci. USA 87:6629-6633
KRISHNA, T. S. R., X. P. KONG, S. GARY, P. BURGERS, and J. KURIYAN, 1994 Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA. Cell 79:1233-1243[Medline].
LEE, S.-H. and J. HURWITZ, 1990 Mechanism of elongation of primed DNA by DNA polymerase delta, proliferating cell nuclear antigen and activator I. Proc. Natl. Acad. Sci. USA 87:5672-5676
LEE, S.-H., Y. ISHIMI, M. K. KENNY, P. BULLOCK, and F. B. DEAN et al., 1988 An inhibitor of the in vitro elongation reaction of simian virus 40 DNA replication is overcome by proliferating-cell nuclear antigen. Proc. Natl. Acad. Sci. USA 85:9469-9473
LEE, S.-H., Z.-Q. PAN, A. D. KWONG, P. M. J. BURGERS, and J. HURWITZ, 1991 Synthesis of DNA by DNA polymerase
in vitro.. J. Biol. Chem. 266:22707-22717
LEVIN, D. and F. HUTCHINSON, 1973 Relation between single-strand DNA mass and sedimentation distance in alkaline sucrose gradients. J. Mol. Biol. 75:495-502[Medline].
LI, X., J. LI, J. HARRINGTON, M. R. LIEBER, and P. M. BURGERS, 1995 Lagging-strand DNA synthesis at the eukaryotic replication fork involves binding and stimulation of FEN-1 by proliferating cell nuclear antigen. J. Biol. Chem. 270:22109-22112
MALKOVA, A., E. L. IVANOV, and J. E. HABER, 1996 Double-strand break repair in the absence of RAD51 in yeast: a possible role for break-induced DNA replication. Proc. Natl. Acad. Sci. USA 93:7131-7136
MALONE, R. E. and M. F. HOEKSTRA, 1984 Relationships between a hyper-rec mutation (REM1) and other recombination and repair genes in yeast. Genetics 107:33-48
MATSUMOTO, Y., K . KIM, and D. F. BOGENHAGEN, 1994 Proliferating cell nuclear antigen-dependent abasic site repair in Xenopus laevis oocytes: an alternative pathway of base excision DNA repair. Mol. Cell. Biol. 14:6187-6197
MCALEAR, M., K . M. TUFFO, and C. HOLM, 1996 The large subunit of replication factor C (Rfc1/Cdc44p) is required for DNA replication and DNA repair in S. cerevisiae.. Genetics 142:65-78[Abstract].
MONK, M. and J. KINROSS, 1972 Conditional lethality of recA and recB derivatives of a strain of Escherichia coli K-12 with a temperature-sensitive deoxyribonucleic acid polymerase I. J. Bacteriol. 109:971-978
MONTELONE, B. A., M. F. HOEKSTRA, and R. E. MALONE, 1988 Sponta-neous mitotic recombination in yeast: the hyper-recombinational rem1 mutations are alleles of the RAD3 gene. Genetics 119:289-301
MONTELONE, B. A., S. PRAKASH, and L. PRAKASH, 1981 Spontaneous mitotic recombination in mms8-1, an allele of the CDC9 gene of Saccharomyces cerevisiae.. J. Bacteriol. 147:517-525





